SGCIA
CCRN

Smith Graham & Co Investment Advisors’s Cross Country Healthcare CCRN Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$5.76M Buy
254,495
+3,796
+2% +$82.3K 0.66% 64
2023
Q3 		$6.21M Buy
250,699
+27,630
+12% +$695K 0.77% 48
2023
Q2 		$6.26M Sell
223,069
-21,183
-9% -$526K 0.76% 52
2023
Q1 		$5.45M Buy
+244,252
New +$6.4M 0.66% 65

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Smith Graham & Co Investment Advisors's CCRN Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors increased its Cross Country Healthcare (CCRN) stake by 1.5% in Q4 2023, buying an estimated $82.3K and bringing the position to 254,495 shares worth $5.76M. The position accounts for 0.66% of the portfolio, ranked #64.

Smith Graham & Co Investment Advisors first reported a position in CCRN in Q1 2023 and has held it in 4 quarters since. The position peaked at $6.26M in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2023.

  • Smith Graham & Co Investment Advisors held 254,495 shares of Cross Country Healthcare worth $5.76M as of Q4 2023.
  • Smith Graham & Co Investment Advisors bought 3,796 Cross Country Healthcare shares in Q4 2023, an estimated $82.3K.
  • Cross Country Healthcare made up 0.66% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #64 holding.
  • Smith Graham & Co Investment Advisors first reported a position in Cross Country Healthcare in Q1 2023 and has held it in 4 quarters since.
  • Smith Graham & Co Investment Advisors's Cross Country Healthcare position peaked at $6.26M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.